-
Better outcome not guaranteed for cancer research volunteers; FDA wants clinical trial database improvements; BRAAN gets smarter.
-
The American Heart Association (AHA) in Dallas has released new guidelines for preventing heart disease and stroke in women that are tailored to each individuals cardiac event risk.
-
While on rotation as a drug information specialty resident, one pharmacist decided to take a more comprehensive look at how much one drug would cost the health center if it were added to the formulary.
-
Memantine (Namenda) helped lessen the symptoms of patients with moderate-to-severe Alzheimers disease (AD) who were already receiving treatment with donepezil (Aricept), according to a study published in the Jan. 21 issue of the Journal of the American Medical Association.
-
New hepatotoxicity warning added to nevirapine (Viramune); FDA announces improved drug approval results in 2003; Savings noted with increased use of beta-blockers; First TB vaccine trial in 60 years to begin; Study: Consumers dont understand drug formularies; Vantin antibiotic batch recalled.
-
-
Hardy ML. Beware or be blue: Does St. John's wort interfere with oral contraceptives? 2004;6(3):20-22.
-
Hardy ML. NAMS recommends some CAM therapies for treating mild hot flashes. Altern Ther Women's Health 2004;6(3):22-23.
-
-
Schiff E. Acupuncture for the treatment of insomnia. Altern Med Alert 2004;7(11):121-124.
